Cost-effectiveness of procedures for treatment of ostium secundum atrial septal defects occlusion comparing conventional surgery and septal percutaneous implant.

Autor: da Costa MG; Centre of Technology Assessment in Health, National Institute of Cardiology, Rio de Janeiro, Brazil., Santos Mda S; Centre of Technology Assessment in Health, National Institute of Cardiology, Rio de Janeiro, Brazil., Sarti FM; University of São Paulo, São Paulo, Brazil., Simões e Senna KM; Centre of Technology Assessment in Health, National Institute of Cardiology, Rio de Janeiro, Brazil., Tura BR; Centre of Technology Assessment in Health, National Institute of Cardiology, Rio de Janeiro, Brazil., Correia MG; Centre of Technology Assessment in Health, National Institute of Cardiology, Rio de Janeiro, Brazil.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2014 Oct 10; Vol. 9 (10), pp. e108966. Date of Electronic Publication: 2014 Oct 10 (Print Publication: 2014).
DOI: 10.1371/journal.pone.0108966
Abstrakt: Objectives: The study performs a cost-effectiveness analysis of procedures for atrial septal defects occlusion, comparing conventional surgery to septal percutaneous implant.
Methods: A model of analytical decision was structured with symmetric branches to estimate cost-effectiveness ratio between the procedures. The decision tree model was based on evidences gathered through meta-analysis of literature, and validated by a panel of specialists. The lower number of surgical procedures performed for atrial septal defects occlusion at each branch was considered as the effectiveness outcome. Direct medical costs and probabilities for each event were inserted in the model using data available from Brazilian public sector database system and information extracted from the literature review, using micro-costing technique. Sensitivity analysis included price variations of percutaneous implant.
Results: The results obtained from the decision model demonstrated that the percutaneous implant was more cost effective in cost-effectiveness analysis at a cost of US$8,936.34 with a reduction in the probability of surgery occurrence in 93% of the cases. Probability of atrial septal communication occlusion and cost of the implant are the determinant factors of cost-effectiveness ratio.
Conclusions: The proposal of a decision model seeks to fill a void in the academic literature. The decision model proposed includes the outcomes that present major impact in relation to the overall costs of the procedure. The atrial septal defects occlusion using percutaneous implant reduces the physical and psychological distress to the patients in relation to the conventional surgery, which represent intangible costs in the context of economic evaluation.
Databáze: MEDLINE
Externí odkaz: